What's new

Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)

Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)

May 27, 2025 - 16:15
 0
Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Inflectra, infliximab,...

Next Article

Start of procedure: Type II variation - extension of indication (26 April - 22 M...

Related Posts

Human medicines European public assessment report (EPAR): Jemperli, dostarlimab, Date of authorisation: 21/04/2021, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 75, Status: Authorised

Human medicines European public assessment report (EPAR...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0